JoanF.KroenerMD

PubMed

• 24 citations
  A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer.
  Adam Brufsky, Karen Hoelzer, Thaddeus Beck, Robert C. Whorf, Mark Keaton, Padma Nadella, Elisa Krill-Jackson, Joan Kroener, Edward Middleman, Michael Frontiera, Devcha...> ;Clinical Breast Cancer. 2011 Aug 1
• 125 citations
  Phase II, Randomized Trial to Compare Anastrozole Combined with Gefitinib or Placebo in Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer
  Massimo Cristofanilli, Vicente Valero, Aroop Mangalik, Melanie Royce, Ian Rabinowitz, Francis P. Arena, Joan Kroener, Elizabeth Curcio, Claire Watkins, Sarah S. Bacus,...> ;Clinical Cancer Research. 2010 Mar 15
• Preliminary results of a randomized phase II study of paclitaxel and bevacizumab ± gemcitabine as first-line treatment for metastatic breast cancer.
  Hoelzer KL, Brufsky A, Hainsworth J, Beck JT, Whorf R, Keaton M, Kroener J, Krill-Jackson E, Hu S, Bromund J> ;J. Clin. Oncol.. 2009-05-20
• A phase II multicenter, double-blind, randomized trial to compare anastrozole plus gefinitib with anastrozole plus placebo in postmenopausal women with hormone recepto...
  Cristofanilli M, Valero V, Mangalik A, Rabinowitz I, Arena FP, Kroener JF, Curcio E, Watkins C, Magill P> ;J. Clin. Oncol.. 2008-05-20
• 241 citations
  Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowe...
  Eleftherios P. Mamounas, Jong-Hyeon Jeong, D. Lawrence Wickerham, Roy E. Smith, Patricia A. Ganz, Stephanie R. Land, Andrea Eisen, Louis Fehrenbacher, William B. Farra...> ;Journal of Clinical Oncology. 2008 Apr 20
• 81 citations
  The use of canines in the detection of human cancers
  Robert T. Gordon, Carole Beck Schatz, Lawrence J Myers, Michael P. Kosty, Constance Gonczy, Joan Kroener, Michael Tran, Pamela Kurtzhals, Susan Heath, James A. Koziol,...> ;Journal of Alternative and Complementary Medicine. 2008 Jan 30
• 118 citations
  Case study of the morphologic variation of circulating tumor cells.
  Dena Marrinucci, Kelly Bethel, Richard H. Bruce, Douglas N. Curry, Ben Hsieh, Mark Humphrey, Robert T. Krivacic, Joan Kroener, Lindsay Kroener, Andras Ladanyi, Nicole ...> ;Human Pathology. 2007 Mar 1
• 116 citations
  High speed detection of circulating tumor cells
  H. Ben Hsieh, Dena Marrinucci, Kelly Bethel, Douglas N. Curry, Mark Humphrey, Robert T. Krivacic, Joan Kroener, Lindsay Kroener, Andras Ladanyi, Nicole Hanson Lazarus,...> ;Biosensors & Bioelectronics. 2006 Apr 15
• 52 citations
  A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer : A phase I trial
  Anna Berkenblit, Ursula A. Matulonis, Joan Kroener, Bruce J. Dezube, Gil N. Lam, Luceli C. Cuasay, Nils Brünner, Terence R. Jones, Michael H. Silverman, Michael A. Gold> ;Gynecologic Oncology. 2005 Oct 1
• Phase II trial of KOS-862 (epothilone D) in anthracycline and taxane pretreated metastatic breast cancer.
  Overmoyer B, Waintraub S, Kaufman PA, Doyle T, Moore H, Modiano M, Kroener J, Zhang X, Buzdar A, Demario M> ;J. Clin. Oncol.. 2005-06-01
• Misleading Title and Abstract in Recent Granulocyte-Macrophage Colony-Stimulating Factor Trial
  Joel S. Grossman, Joan Kroener> ;Journal of Clinical Oncology. 1999 May 1
• 59 citations
  Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignancies.
  William E. Miller, Robert McMillan, Mary Callaghan, Christine Sloan, Terry Brehm, Michael P. Kosty, Joan Kroener, Robert L. Longmire, Alan Saven, Lawrence D. Piro> ;Journal of Clinical Oncology. 1997 Jan 1
• 67 citations
  Phase I Clinical Comparative Study of Monoclonal Antibody KS1/4 and KS1/4-Methotrexate Immunconjugate in Patients with Non-Small Cell Lung Carcinoma
  Darlene J. Elias, Lynn Hirschowitz, Lawrence E. Kline, Joan Kroener, Robert O. Dillman, Leslie E. Walker, James A. Robb, Richard M. Timms> ;Cancer Research. 1990 Jul 1
• Alternating combination chemotherapy for stages III and IV ovarian carcinoma.
  Young, J. A., Johnson, A., Kroener, J., Koziol, J. A., Saltzstein, S., Yon, J. L., Campbell, T. N., Lucas, W., Green, M. R.> ;J Clin Oncol. 1984 Dec
• 5-FU and allopurinol: toxicity modulation and phase II results in colon cancer.
  Kroener, J. F., Saleh, F., Howell, S. B.> ;Cancer Treat Rep. 1982 May
• Acute myelofibrosis. Treatment with allogeneic bone marrow transplantation.
  Kroener, J. F., McMillan, R., Beutler, E.> ;JAMA. 1983 Mar 4
• Join now to see all